INmune Bio (INMB)

• Market cap: $47.9M
• 1 day: 7.78%
• 5 days: 10.43%
• 1 month: 8.43%
• 3 months: -2.17%
• 6 months: -38.14%
• Year to date: 16.88%
• 1 year: -77.24%
• 5 years: -90.42%
• 10 years: -77.47%
• Sector: Healthcare
• Industry: Biotechnology

About: INmune Bio Inc is a clinical-stage biotechnology company. It is engaged in the development of new immunotherapies that reprogram a patient's innate immune system to allow immune system to fight cancer. The company's pipeline products include INKmune, INBO3, XPro1595, LIVNate, and others.

Employees: 13